Abstract:Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and different viral serotypes, promoters and transduction pathways can influence the targeting of AAV to different types of cells and the expression levels of numerous exogenous genes. To determine the transduction and expression patterns of AAV with different serotypes or promoters in hair cells and supporting cells in the neonatal mouse cochlea, we examined the expression of enhanced green fluorescent protein (eGFP) for five different types of AAV vectors [serotypes 2, 9, and Anc80L65 with promoter cytomegalovirus (CMV)-beta-Globin and serotypes 2 and 9 with promoter chicken beta-actin (CBA)] in in vitro cochlear explant cultures and we tested the transduction of AAV2/2-CBA, AAV2/9-CBA, and AAV2/Anc80L65-CMV by in vivo microinjection into the scala media of the cochlea. We found that each AAV vector had its own transduction and expression characteristics in hair cells and supporting cells in different regions of the cochlea. There was a tonotopic gradient for the in vitro transduction of AAV2/2-CBA, AAV2/9-CBA, AAV2/2-CMV, and AAV2/9-CMV in outer hair cells (OHCs), with more OHCs expressing eGFP at the base of the cochlea than at the apex. AAV2/2-CBA in vitro and AAV2/Anc80L65-CMV in vivo induced more supporting cells expressing eGFP at the apex than in the base. We found that AAV vectors with different promoters had different expression efficacies in hair cells and supporting cells of the auditory epithelium. The CMV-beta-Globin promoter could drive the expression of the delivered construct more efficiently in hair cells, while the CBA promoter was more efficient in supporting cells. The in vitro and in vivo experiments both demonstrated that AAV2/Anc80L65-CMV was a very promising vector for gene therapy of deafness because of its high transduction rates in hair cells. These results might be useful for selecting the appropriate vectors for gene delivery into different types of inner ear cells and thus improving the effectiveness of gene therapy.

663. Protection Against Aminoglycoside-Induced Ototoxicity by AAV Vector-Mediated GDNF Gene Transfer into the Cochlea

Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector-mediated GDNF Gene Transfer into the Cochlea.

Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector|[ndash]|mediated GDNF Gene Transfer Into the Cochlea

Effects of Adeno-Associated Virus Vector-Mediated GDNF Gene Transfer on Kanamycin-Induced Cochlear Toxicity

A study of a postauricular approach to rat cochlear scala media lateral wall for microinject lentivirus with EGFP

[Experimental Study on Embryonic Neural Stem Cells Transplantation into Natural Rat Cochlea Via Round Window].

Study on neural stem cell transplantation into natural rat cochlea via round window.

Gene Therapy with Adeno-Associated Virus Vector-Mediated Extracellular Superoxide Dismutase Attenuates Kanamycin-induced Cochlear Damage

Delivery of Adeno-Associated Virus Vectors in Adult Mammalian Inner-Ear Cell Subtypes Without Auditory Dysfunction

AAV-ie-K558R mediated cochlear gene therapy and hair cell regeneration

Early postnatal virus inoculation into the scala media achieved extensive expression of exogenous green fluorescent protein in the inner ear and preserved auditory brainstem response thresholds.

Approaches and Vectors for Efficient Cochlear Gene Transfer in Adult Mouse Models

Transduction of Adeno-Associated Virus Vectors Targeting Hair Cells and Supporting Cells in the Neonatal Mouse Cochlea

AAV-ie Enables Safe and Efficient Gene Transfer to Inner Ear Cells.

Specific and Efficient Transduction of Cochlear Inner Hair Cells with Recombinant Adeno-Associated Virus Type 3 Vector

Protective Role of Glial Cell Line-Derived Neurotrophic Factor Following Ototoxic

Cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction

Enhanced Cochlear Transduction by AAV9 with High-Concentration Sucrose

In Vivo Delivery of Atoh1 Gene to Rat Cochlea Using a Dendrimer-Based Nanocarrier.

Adeno-associated Virus-Mediated Bcl-XL Prevents Aminoglycosideinduced Hearing Loss in Mice

AAV2.7m8 is a powerful viral vector for inner ear gene therapy